MSD-XXX Future Programs

About Mindstate Design Labs

Mindstate Design Labs is pioneering a data-driven approach to psychedelic therapeutics by combining AI, pharmacology, and human experience reports. Its core asset is the Osmanthus platform, which analyzes vast datasets to identify how specific neurotransmitter receptor combinations produce distinct psychoactive states, guiding the design of novel compounds. The lead program, MSD-001, is in human studies and is designed to induce emotional and cognitive flexibility, with follow-on programs targeting other specific states. The company is led by a team with expertise in biotechnology investing, evolutionary biology, and CNS drug development, positioning it at the intersection of AI and next-generation mental health treatments.

Therapeutic Areas